Gene Polymorphism in Tinea Versicolor

Kasr El Aini Hospital

Status: Unknown

Conditions: Recurrent Pityriasis Versicolor

Study type: Observational

Funder types: Other

Identifiers

NCT04769804

PolymorphismTV

Details and patient eligibility

About

Blood samples will be taken from cases presenting with recurrent tinea versicolor , after confirmation of diagnosis by wood's light and KOH examination, for the detection of gene polymorphism in IL17 A and IL17 F.

In addition , serum samples from patients and controls will be tested for 25(OH)2 D3

Enrollment: 200 estimated patients

Sex: All

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• • Patients with recurrent pityriasis versicolor (active now) and not taking treatment for it.
• Patients of both genders.
• Age ≥18 years old.

Exclusion criteria

• • Patients with other cutaneous diseases.
• Patient's having dandruff (scaly scalp) even if not symptomatizing.
• Pregnant and lactating females, children, prisoners, cognitively impaired or mentally disabled subjects.
• Patients with autoimmune diseases.
• Patients with immunodeficiency diseases.
• Immunosuppressed patients e.g. HIV, diabetics, organ transplant, malignancy, patients taking immunosuppressive drugs e.g. chemotherapy, cortisone.

Trial design

200 participants in 2 patient groups

Patients with recurrent pityriasis versicolor

Healthy age and sex-matched controls